List of Excipients in API ACYCLOVIR
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ACYCLOVIR
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA Inc | ACYCLOVIR | acyclovir | 0093-3630 | CETOSTEARYL ALCOHOL | |
| Teva Pharmaceuticals USA Inc | ACYCLOVIR | acyclovir | 0093-3630 | MINERAL OIL | |
| Teva Pharmaceuticals USA Inc | ACYCLOVIR | acyclovir | 0093-3630 | PETROLATUM | |
| Teva Pharmaceuticals USA Inc | ACYCLOVIR | acyclovir | 0093-3630 | POLOXAMER 407 | |
| Teva Pharmaceuticals USA Inc | ACYCLOVIR | acyclovir | 0093-3630 | PROPYLENE GLYCOL | |
| Teva Pharmaceuticals USA Inc | ACYCLOVIR | acyclovir | 0093-3630 | SODIUM LAURYL SULFATE | |
| Teva Pharmaceuticals USA Inc | ACYCLOVIR | acyclovir | 0093-3630 | WATER | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing ACYCLOVIR
Detailed excipient profiles for ACYCLOVIR
Excipient focus: ALCOHOL
ACYCLOVIR drug variants containing ALCOHOL
ACYCLOVIR drug variants not containing ALCOHOL
Excipient focus: ALUMINUM OXIDE
ACYCLOVIR drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Apotheca Inc | acyclovir | 12634-520 |
| QPharma Inc | acyclovir | 42708-073 |
| Bryant Ranch Prepack | acyclovir | 63629-1677 |
| Bryant Ranch Prepack | acyclovir | 63629-7001 |
| RedPharm Drug Inc | acyclovir | 67296-0240 |
| RedPharm Drug Inc | acyclovir | 67296-1054 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing ALUMINUM OXIDE
Excipient focus: AMMONIA
ACYCLOVIR drug variants containing AMMONIA
ACYCLOVIR drug variants not containing AMMONIA
Excipient focus: BANANA
ACYCLOVIR drug variants containing BANANA
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | acyclovir | 23155-485 |
| Akorn | acyclovir | 50383-810 |
| Aurobindo Pharma Limited | acyclovir | 59651-493 |
| Chartwell RX LLC | acyclovir | 62135-803 |
| Advagen Pharma Limited | acyclovir | 72888-079 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing BANANA
Excipient focus: BROWN IRON OXIDE
ACYCLOVIR drug variants containing BROWN IRON OXIDE
ACYCLOVIR drug variants not containing BROWN IRON OXIDE
Excipient focus: BUTYL ALCOHOL
ACYCLOVIR drug variants containing BUTYL ALCOHOL
ACYCLOVIR drug variants not containing BUTYL ALCOHOL
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
ACYCLOVIR drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
ACYCLOVIR drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ACYCLOVIR drug variants containing CELLULOSE, MICROCRYSTALLINE
ACYCLOVIR drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CETOSTEARYL ALCOHOL
ACYCLOVIR drug variants containing CETOSTEARYL ALCOHOL
ACYCLOVIR drug variants not containing CETOSTEARYL ALCOHOL
Excipient focus: CITRIC ACID MONOHYDRATE
ACYCLOVIR drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: COLLOIDAL SILICON DIOXIDE
ACYCLOVIR drug variants containing COLLOIDAL SILICON DIOXIDE
ACYCLOVIR drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSCARMELLOSE SODIUM
ACYCLOVIR drug variants containing CROSCARMELLOSE SODIUM
ACYCLOVIR drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
ACYCLOVIR drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Preferred Pharmaceuticals Inc | acyclovir | 68788-7576 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing CROSPOVIDONE
Excipient focus: D&C RED NO. 28
ACYCLOVIR drug variants containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | acyclovir | 10544-101 |
| Aidarex Pharmaceuticals LLC | acyclovir | 33261-419 |
| HJ Harkins Company Inc | acyclovir | 52959-517 |
| Proficient Rx LP | acyclovir | 63187-154 |
| Bryant Ranch Prepack | acyclovir | 63629-1676 |
| Bryant Ranch Prepack | acyclovir | 63629-7001 |
| RedPharm Drug Inc | acyclovir | 67296-0240 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing D&C RED NO. 28
Excipient focus: D&C RED NO. 33
ACYCLOVIR drug variants containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | acyclovir | 10544-101 |
| Aidarex Pharmaceuticals LLC | acyclovir | 33261-419 |
| HJ Harkins Company Inc | acyclovir | 52959-517 |
| Proficient Rx LP | acyclovir | 63187-154 |
| Bryant Ranch Prepack | acyclovir | 63629-1676 |
| Bryant Ranch Prepack | acyclovir | 63629-7001 |
| RedPharm Drug Inc | acyclovir | 67296-0240 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing D&C RED NO. 33
Excipient focus: D&C YELLOW NO. 10
ACYCLOVIR drug variants containing D&C YELLOW NO. 10
ACYCLOVIR drug variants not containing D&C YELLOW NO. 10
Excipient focus: FD&C BLUE NO. 1
ACYCLOVIR drug variants containing FD&C BLUE NO. 1
ACYCLOVIR drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
ACYCLOVIR drug variants containing FD&C BLUE NO. 2
ACYCLOVIR drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 3
ACYCLOVIR drug variants containing FD&C RED NO. 3
ACYCLOVIR drug variants not containing FD&C RED NO. 3
Excipient focus: FD&C RED NO. 40
ACYCLOVIR drug variants containing FD&C RED NO. 40
ACYCLOVIR drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
ACYCLOVIR drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | acyclovir | 62135-039 |
| YILING PHARMACEUTICAL INC | acyclovir | 69117-0039 |
| EMC PHARMA LLC | acyclovir | 81288-039 |
| The Davinci Company | acyclovir | 82951-002 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
ACYCLOVIR drug variants containing FERRIC OXIDE RED
ACYCLOVIR drug variants not containing FERRIC OXIDE RED
Excipient focus: FERROSOFERRIC OXIDE
ACYCLOVIR drug variants containing FERROSOFERRIC OXIDE
ACYCLOVIR drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
ACYCLOVIR drug variants containing GELATIN
ACYCLOVIR drug variants not containing GELATIN
Excipient focus: GLYCERIN
ACYCLOVIR drug variants containing GLYCERIN
ACYCLOVIR drug variants not containing GLYCERIN
Excipient focus: HYDROCHLORIC ACID
ACYCLOVIR drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYPROMELLOSE 2208
ACYCLOVIR drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Cipher Pharmaceuticals US LLC | acyclovir | 68712-049 |
| EPI Health Inc | acyclovir | 71403-049 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing HYPROMELLOSE 2208
Excipient focus: INDIGOTINDISULFONATE SODIUM
ACYCLOVIR drug variants containing INDIGOTINDISULFONATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Proficient Rx LP | acyclovir | 63187-154 |
| Bryant Ranch Prepack | acyclovir | 63629-7001 |
| RedPharm Drug Inc | acyclovir | 67296-0240 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing INDIGOTINDISULFONATE SODIUM
Excipient focus: ISOPROPYL ALCOHOL
ACYCLOVIR drug variants containing ISOPROPYL ALCOHOL
ACYCLOVIR drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: ISOPROPYL MYRISTATE
ACYCLOVIR drug variants containing ISOPROPYL MYRISTATE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing ISOPROPYL MYRISTATE
Excipient focus: LACTOSE MONOHYDRATE
ACYCLOVIR drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | acyclovir | 10544-089 |
| Blenheim Pharmacal Inc | acyclovir | 10544-101 |
| Blenheim Pharmacal Inc | acyclovir | 10544-102 |
| Blenheim Pharmacal Inc | acyclovir | 10544-103 |
| Apotheca Inc | acyclovir | 12634-520 |
| Rebel Distributors Corp | acyclovir | 21695-009 |
| Aidarex Pharmaceuticals LLC | acyclovir | 33261-419 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
ACYCLOVIR drug variants containing MAGNESIUM STEARATE
ACYCLOVIR drug variants not containing MAGNESIUM STEARATE
Excipient focus: METHYLPARABEN
ACYCLOVIR drug variants containing METHYLPARABEN
ACYCLOVIR drug variants not containing METHYLPARABEN
Excipient focus: MINERAL OIL
ACYCLOVIR drug variants containing MINERAL OIL
ACYCLOVIR drug variants not containing MINERAL OIL
Excipient focus: NONCRYSTALLIZING SORBITOL SOLUTION
ACYCLOVIR drug variants containing NONCRYSTALLIZING SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | acyclovir | 31722-681 |
| Aurobindo Pharma Limited | acyclovir | 59651-493 |
| Chartwell RX LLC | acyclovir | 62135-803 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing NONCRYSTALLIZING SORBITOL SOLUTION
Excipient focus: PETROLATUM
ACYCLOVIR drug variants containing PETROLATUM
ACYCLOVIR drug variants not containing PETROLATUM
Excipient focus: POLOXAMER 188
ACYCLOVIR drug variants containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing POLOXAMER 188
Excipient focus: POLOXAMER 407
ACYCLOVIR drug variants containing POLOXAMER 407
ACYCLOVIR drug variants not containing POLOXAMER 407
Excipient focus: POLYETHYLENE GLYCOL
ACYCLOVIR drug variants containing POLYETHYLENE GLYCOL
ACYCLOVIR drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 1450
ACYCLOVIR drug variants containing POLYETHYLENE GLYCOL 1450
| Company | Ingredient | NDC |
|---|---|---|
| Solco Healthcare US LLC | acyclovir | 43547-499 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing POLYETHYLENE GLYCOL 1450
Excipient focus: POLYETHYLENE GLYCOL 300
ACYCLOVIR drug variants containing POLYETHYLENE GLYCOL 300
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | acyclovir | 13668-515 |
| Solco Healthcare US LLC | acyclovir | 43547-499 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing POLYETHYLENE GLYCOL 300
Excipient focus: POTASSIUM HYDROXIDE
ACYCLOVIR drug variants containing POTASSIUM HYDROXIDE
ACYCLOVIR drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POVIDONE
ACYCLOVIR drug variants containing POVIDONE
ACYCLOVIR drug variants not containing POVIDONE
Excipient focus: POVIDONE K25
ACYCLOVIR drug variants containing POVIDONE K25
ACYCLOVIR drug variants not containing POVIDONE K25
Excipient focus: POVIDONE K30
ACYCLOVIR drug variants containing POVIDONE K30
ACYCLOVIR drug variants not containing POVIDONE K30
Excipient focus: POVIDONES
ACYCLOVIR drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | acyclovir | 53808-0609 |
| MedVantx Inc | acyclovir | 66116-414 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing POVIDONES
Excipient focus: PROPYLENE GLYCOL
ACYCLOVIR drug variants containing PROPYLENE GLYCOL
ACYCLOVIR drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
ACYCLOVIR drug variants containing PROPYLPARABEN
ACYCLOVIR drug variants not containing PROPYLPARABEN
Excipient focus: SHELLAC
ACYCLOVIR drug variants containing SHELLAC
ACYCLOVIR drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
ACYCLOVIR drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Liberty Pharmaceuticals Inc | acyclovir | 0440-7033 |
| Major Pharmaceuticals | acyclovir | 0904-5789 |
| Major Pharmaceuticals | acyclovir | 0904-5790 |
| Blenheim Pharmacal Inc | acyclovir | 10544-102 |
| Blenheim Pharmacal Inc | acyclovir | 10544-103 |
| Apotheca Inc | acyclovir | 12634-520 |
| Apotheca Inc | acyclovir | 12634-697 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM HYDROXIDE
ACYCLOVIR drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals (USA) Inc | acyclovir | 68382-048 |
| Zydus Pharmaceuticals USA Inc | acyclovir | 68382-125 |
| Zydus Lifesciences Limited | acyclovir | 70771-1081 |
| Zydus Lifesciences Limited | acyclovir | 70771-1383 |
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURETH SULFATE
ACYCLOVIR drug variants containing SODIUM LAURETH SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Carlsbad Technology Inc | acyclovir | 61442-111 |
| RedPharm Drug Inc | acyclovir | 67296-0656 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing SODIUM LAURETH SULFATE
Excipient focus: SODIUM LAURETH-3 SULFATE
ACYCLOVIR drug variants containing SODIUM LAURETH-3 SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | acyclovir | 50090-0596 |
| Proficient Rx LP | acyclovir | 63187-182 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing SODIUM LAURETH-3 SULFATE
Excipient focus: SODIUM LAURYL SULFATE
ACYCLOVIR drug variants containing SODIUM LAURYL SULFATE
ACYCLOVIR drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
ACYCLOVIR drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
ACYCLOVIR drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SORBITOL
ACYCLOVIR drug variants containing SORBITOL
ACYCLOVIR drug variants not containing SORBITOL
Excipient focus: SORBITOL SOLUTION
ACYCLOVIR drug variants containing SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| Novadoz Pharmaceuticals LLC | acyclovir | 72205-170 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing SORBITOL SOLUTION
Excipient focus: STARCH, CORN
ACYCLOVIR drug variants containing STARCH, CORN
ACYCLOVIR drug variants not containing STARCH, CORN
Excipient focus: STARCH, PREGELATINIZED CORN
ACYCLOVIR drug variants containing STARCH, PREGELATINIZED CORN
ACYCLOVIR drug variants not containing STARCH, PREGELATINIZED CORN
Excipient focus: TALC
ACYCLOVIR drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| RPK Pharmaceuticals Inc | acyclovir | 53002-0080 |
| RPK Pharmaceuticals Inc | acyclovir | 53002-0081 |
| RedPharm Drug Inc | acyclovir | 67296-1625 |
| Cadila Pharmaceuticals Limited | acyclovir | 71209-005 |
| Modavar Pharmaceuticals LLC | acyclovir | 72241-026 |
| Nivagen Pharmaceuticals Inc | acyclovir | 75834-122 |
| >Company | >Ingredient | >NDC |
ACYCLOVIR drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
ACYCLOVIR drug variants containing TITANIUM DIOXIDE
ACYCLOVIR drug variants not containing TITANIUM DIOXIDE
Excipient focus: WATER
ACYCLOVIR drug variants containing WATER
ACYCLOVIR drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
